Huadong Medicine Co Ltd (000963) — Cash Flow-to-Debt Ratio
Huadong Medicine Co Ltd (000963) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥155.98 Million could theoretically repay 0% of its total liabilities (CN¥15.43 Billion) in one year. See 000963 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Huadong Medicine Co Ltd Cash Flow-to-Debt Ratio (1998–2024)
Historical debt coverage capacity for Huadong Medicine Co Ltd across 27 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Huadong Medicine Co Ltd.
Annual Cash Flow-to-Debt Ratio for Huadong Medicine Co Ltd (1998–2024)
Year-by-year debt coverage analysis for Huadong Medicine Co Ltd. Check Huadong Medicine Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.26x | CN¥3.75 Billion | CN¥14.32 Billion | ▼ -20.5% |
| 2023 | 0.33x | CN¥3.93 Billion | CN¥11.93 Billion | ▲ +66.2% |
| 2022 | 0.20x | CN¥2.38 Billion | CN¥12.02 Billion | ▼ -37.1% |
| 2021 | 0.32x | CN¥3.17 Billion | CN¥10.06 Billion | ▼ -16.6% |
| 2020 | 0.38x | CN¥3.41 Billion | CN¥9.02 Billion | ▲ +62.4% |
| 2019 | 0.23x | CN¥2.00 Billion | CN¥8.60 Billion | ▲ +0.4% |
| 2018 | 0.23x | CN¥2.04 Billion | CN¥8.79 Billion | ▲ +0.2% |
| 2017 | 0.23x | CN¥1.66 Billion | CN¥7.18 Billion | ▲ +17.1% |
| 2016 | 0.20x | CN¥1.35 Billion | CN¥6.81 Billion | ▲ +145.3% |
| 2015 | 0.08x | CN¥658.54 Million | CN¥8.17 Billion | ▼ -29.4% |
| 2014 | 0.11x | CN¥740.85 Million | CN¥6.49 Billion | ▲ +11.5% |
| 2013 | 0.10x | CN¥476.98 Million | CN¥4.66 Billion | ▼ -33.1% |
| 2012 | 0.15x | CN¥642.73 Million | CN¥4.20 Billion | ▲ +3746.2% |
| 2011 | 0.00x | CN¥16.12 Million | CN¥4.05 Billion | ▲ +141.4% |
| 2010 | -0.01x | CN¥-27.99 Million | CN¥2.91 Billion | ▼ -103.9% |
| 2009 | 0.25x | CN¥567.94 Million | CN¥2.27 Billion | ▲ +59.3% |
| 2008 | 0.16x | CN¥344.69 Million | CN¥2.20 Billion | ▲ +7.2% |
| 2007 | 0.15x | CN¥265.79 Million | CN¥1.82 Billion | ▲ +307.0% |
| 2006 | 0.04x | CN¥57.38 Million | CN¥1.60 Billion | ▼ -75.8% |
| 2005 | 0.15x | CN¥203.33 Million | CN¥1.37 Billion | ▲ +1231.7% |
| 2004 | 0.01x | CN¥12.51 Million | CN¥1.12 Billion | ▼ -90.2% |
| 2003 | 0.11x | CN¥90.54 Million | CN¥797.04 Million | ▲ +262.0% |
| 2002 | 0.03x | CN¥23.94 Million | CN¥763.14 Million | ▼ -81.0% |
| 2001 | 0.17x | CN¥109.67 Million | CN¥663.14 Million | ▲ +429.4% |
| 2000 | 0.03x | CN¥19.59 Million | CN¥627.09 Million | ▼ -72.2% |
| 1999 | 0.11x | CN¥56.32 Million | CN¥501.93 Million | ▲ +119.9% |
| 1998 | 0.05x | CN¥23.80 Million | CN¥466.47 Million | — |